in | |||||
NEWS | |||||
Artificial intelligence in COVID-19 drug repurposing These merits are especially clear in the COVID-19 global pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), where ...
| |||||
How can we sustain progress in cancer care in the COVID-19 era? Worse outcomes are likely in lower-income settings. This threatens to reverse the remarkable progress that has been made against cancer in recent ...
| |||||
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
No comments:
Post a Comment